Molecular Omics publishes high-quality research from across the -omics sciences that provide significant new insight into important chemical or biological problems. Topics covered by Molecular Omics include, but are not limited to, proteomics, genomics, transcriptomics, lipidomics, glycomics, metabolomics, microbiomics, sequencing technologies and bioinformatic research. Molecular Omics articles report research that significantly increases understanding or demonstrates clear functional benefits, supported by experimental validation or a novel data analytic approach. Topics include, but are not limited to: -omics studies to gain mechanistic insight into biological processes; -omics studies for clinical applications with experimental validation, such as finding biomarkers for diagnostics or potential new drug targets; -omics studies looking at the sub-cellular make-up of cells – for example, the subcellular localisation of certain proteins or post-translational modifications or new imaging techniques; studies presenting new methods and tools to support omics studies, including new spectroscopic/chromatographic techniques, chip-based/array technologies and new classification/data analysis techniques.
RSC Chemical Biology is a gold open access journal dedicated to publishing and disseminating exceptional, breakthrough research and high-quality reviews at the interface of chemistry and biology. We welcome contributions from across the breadth of the chemical biology field. This includes Sensing and Imaging, Bioorthogonal chemistry, Biosynthesis, Biomimetics and Bioengineering, Synthetic biology, Directed evolution, Drugs development and mechanism of action, Glycoscience, Natural products, Nucleic acids, Peptides, Phenotypic screening, Proteins (including protein-protein interactions, modifications, structure and function) We are particularly interested in reports on the application of chemical tools to probe, explore and visualize biological systems and processes to provide insights into molecular mechanisms in health and disease. We also encourage translational research that bridges chemistry and chemical biology to medicine.